Cvrx Inc (CVRX)

$7.06 +0.26 (3.75%)
Market Cap 177.43M
Revenue (ttm) 51.29M
Net Income (ttm) -59.97M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -116.92%
Debt to Equity Ratio 0.71
Volume 425,500
Avg Vol 258,916
Day's Range N/A - N/A
Shares Out 26.07M
Stochastic %K 25%
Beta 1.27
Analysts Strong Sell
Price Target $14.00

Company Profile

CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, a neuromodulation device that enhance symptoms for patients with heart failure by delivering electrical pulses to baroreceptors. It sells its products through direct sales force, sales agents, and independent distributors. The company was...

Industry: Medical Devices
Sector: Healthcare
Phone: 763 416 2840
Fax: 763 416 2841
Address:
9201 West Broadway Avenue, Suite 650, Minneapolis, United States
MedDevice
MedDevice Aug. 7 at 1:07 PM
$CVRX Analysts are asking the wrong question. Why cant per center implants and Rev per center grow? "Dabblers" are not an adequate answer. Why the need to breakout an internal metric like Tier 3 and 4 centers? Just to justify an increase in active centers this quarter?
0 · Reply
bballz
bballz Aug. 5 at 3:41 PM
$CVRX my condolences to Donald.
0 · Reply
bballz
bballz Aug. 5 at 2:01 PM
$CVRX the company should stop posting first implant pictures... embarrassing, right Donald?
1 · Reply
bballz
bballz Aug. 5 at 1:35 PM
$CVRX sales channel challenges continue to burden investors.
0 · Reply
bballz
bballz Aug. 5 at 1:03 PM
$CVRX dead $$$ until real sales traction is noted.
0 · Reply
JarvisFlow
JarvisFlow Aug. 5 at 12:30 PM
Cantor Fitzgerald updates rating for CVRx ( $CVRX ) to Overweight, target set at 11.
0 · Reply
MITornado
MITornado Aug. 4 at 9:11 PM
$CVRX Good call. We’ll get there eventually. Slow and steady.
1 · Reply
bballz
bballz Aug. 4 at 9:00 PM
$CVRX Ceo says sales reps are gaining traction, cant wait to see what that looks like in increased revenue/guidance next year, right Donald?
1 · Reply
bballz
bballz Aug. 4 at 8:23 PM
$CVRX Lowered high end revenue guidance from $58 to 57m...upped low end expense from $95 to 96m
0 · Reply
bballz
bballz Aug. 4 at 7:15 PM
$CVRX look for the other shoe to drop
1 · Reply
Latest News on CVRX
CVRx, Inc. (CVRX) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 7:27 PM EDT - 2 days ago

CVRx, Inc. (CVRX) Q2 2025 Earnings Call Transcript

CVRx Reports Second Quarter 2025 Financial and Operating Results

Aug 4, 2025, 4:05 PM EDT - 2 days ago

CVRx Reports Second Quarter 2025 Financial and Operating Results

CVRx to Present at the Canaccord Genuity 45th Annual Growth Conference

Jul 29, 2025, 8:30 AM EDT - 9 days ago

CVRx to Present at the Canaccord Genuity 45th Annual Growth Conference

CVRx Announces Positive News on Outpatient Payment for Barostim

Jul 16, 2025, 7:30 AM EDT - 22 days ago

CVRx Announces Positive News on Outpatient Payment for Barostim

CVRx: Sell-Off Ignores Its True Potential

Jul 2, 2025, 4:02 AM EDT - 5 weeks ago

CVRx: Sell-Off Ignores Its True Potential

CVRx to Present at the William Blair 45th Annual Growth Stock Conference

May 28, 2025, 4:30 PM EDT - 2 months ago

CVRx to Present at the William Blair 45th Annual Growth Stock Conference

CVRx, Inc. (CVRX) Q1 2025 Earnings Conference Call Transcript

May 10, 2025, 3:51 PM EDT - 3 months ago

CVRx, Inc. (CVRX) Q1 2025 Earnings Conference Call Transcript

CVRx to Report First Quarter 2025 Financial and Operating Results and Host Conference Call on May 8, 2025

Apr 24, 2025, 4:30 PM EDT - 3 months ago

CVRx to Report First Quarter 2025 Financial and Operating Results and Host Conference Call on May 8, 2025

CVRx Inc: Overreaction Creates Buying Opportunity

Apr 9, 2025, 8:45 AM EDT - 4 months ago

CVRx Inc: Overreaction Creates Buying Opportunity

Greenbrier, RPM International, CVRx And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Apr 8, 2025, 8:35 AM EDT - 4 months ago

Greenbrier, RPM International, CVRx And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

GBX RPM

CVRx Reports Preliminary First Quarter 2025 Financial Results

Apr 7, 2025, 4:05 PM EDT - 4 months ago

CVRx Reports Preliminary First Quarter 2025 Financial Results

CVRx announces new real-world evidence demonstrating significant reductions in healthcare utilization with Barostim

Feb 12, 2025, 2:45 PM EST - 6 months ago

CVRx announces new real-world evidence demonstrating significant reductions in healthcare utilization with Barostim

CVRx, Inc. (CVRX) Q4 2024 Earnings Conference Call Transcript

Feb 4, 2025, 11:00 PM EST - 6 months ago

CVRx, Inc. (CVRX) Q4 2024 Earnings Conference Call Transcript

CVRx Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

Feb 4, 2025, 4:05 PM EST - 6 months ago

CVRx Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

CVRx to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call on February 4, 2025

Jan 21, 2025, 4:30 PM EST - 7 months ago

CVRx to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call on February 4, 2025

CVRx to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 23, 2024, 4:30 PM EST - 8 months ago

CVRx to Present at the 43rd Annual J.P. Morgan Healthcare Conference

CVRx to Present at the Piper Sandler 36th Annual Healthcare Conference

Nov 20, 2024, 4:30 PM EST - 9 months ago

CVRx to Present at the Piper Sandler 36th Annual Healthcare Conference

CVRx: Impressive Top-Line Growth Seems Priced In

Nov 6, 2024, 9:04 PM EST - 9 months ago

CVRx: Impressive Top-Line Growth Seems Priced In

CVRx, Inc. (CVRX) Q3 2024 Earnings Call Transcript

Oct 29, 2024, 10:38 PM EDT - 10 months ago

CVRx, Inc. (CVRX) Q3 2024 Earnings Call Transcript

CVRx announces new CPT® Category I codes for Barostim

Oct 18, 2024, 2:08 PM EDT - 10 months ago

CVRx announces new CPT® Category I codes for Barostim

CVRx to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call on October 29, 2024

Oct 15, 2024, 4:30 PM EDT - 10 months ago

CVRx to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call on October 29, 2024

CVRx Announces Appointment of Two New Board Members

Sep 3, 2024, 8:30 AM EDT - 1 year ago

CVRx Announces Appointment of Two New Board Members

CVRx, Inc. (CVRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Aug 19, 2024, 4:00 PM EDT - 1 year ago

CVRx, Inc. (CVRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

The Schall Law Firm Is Investigating CVRx Inc For Securities Fraud And Urging Investors To Join

Aug 19, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Investigating CVRx Inc For Securities Fraud And Urging Investors To Join

The Schall Law Firm Is Seeking CVRx Inc Shareholders To Join Fraud Investigation

Aug 18, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Seeking CVRx Inc Shareholders To Join Fraud Investigation

CVRx Inc Shareholders Can Join Fraud Investigation With The Schall Law Firm

Aug 17, 2024, 11:00 AM EDT - 1 year ago

CVRx Inc Shareholders Can Join Fraud Investigation With The Schall Law Firm

CVRx Inc Investors Encouraged To Participate In Fraud Inquiry With The Schall Law Firm

Aug 16, 2024, 11:00 AM EDT - 1 year ago

CVRx Inc Investors Encouraged To Participate In Fraud Inquiry With The Schall Law Firm

CVRx Inc Shareholders Urged To Participate In Fraud Inquiry With The Schall Law Firm

Aug 15, 2024, 11:00 AM EDT - 1 year ago

CVRx Inc Shareholders Urged To Participate In Fraud Inquiry With The Schall Law Firm

CVRx Inc Shareholders Invited To Join Fraud Inquiry With The Schall Law Firm

Aug 14, 2024, 10:30 PM EDT - 1 year ago

CVRx Inc Shareholders Invited To Join Fraud Inquiry With The Schall Law Firm

CVRx Inc Investors May Participate In Fraud Investigation With The Schall Law Firm

Aug 14, 2024, 12:30 AM EDT - 1 year ago

CVRx Inc Investors May Participate In Fraud Investigation With The Schall Law Firm

CVRx Inc Investors Urged To Join The Fraud Investigation With The Schall Law Firm

Aug 13, 2024, 2:00 AM EDT - 1 year ago

CVRx Inc Investors Urged To Join The Fraud Investigation With The Schall Law Firm

CVRx Inc Investors Encouraged to Participate in Fraud Investigation With The Schall Law Firm

Aug 9, 2024, 8:30 PM EDT - 1 year ago

CVRx Inc Investors Encouraged to Participate in Fraud Investigation With The Schall Law Firm

CVRx Inc Investors Can Join Fraud Investigation With The Schall Law Firm

Aug 8, 2024, 4:00 PM EDT - 1 year ago

CVRx Inc Investors Can Join Fraud Investigation With The Schall Law Firm

CVRx Inc Investors Are Eligible To Join Fraud Investigation With The Schall Law Firm

Aug 7, 2024, 4:15 PM EDT - 1 year ago

CVRx Inc Investors Are Eligible To Join Fraud Investigation With The Schall Law Firm

CVRx Inc Investors Can Participate In Fraud Investigation With The Schall Law Firm

Aug 6, 2024, 3:30 PM EDT - 1 year ago

CVRx Inc Investors Can Participate In Fraud Investigation With The Schall Law Firm

MedDevice
MedDevice Aug. 7 at 1:07 PM
$CVRX Analysts are asking the wrong question. Why cant per center implants and Rev per center grow? "Dabblers" are not an adequate answer. Why the need to breakout an internal metric like Tier 3 and 4 centers? Just to justify an increase in active centers this quarter?
0 · Reply
bballz
bballz Aug. 5 at 3:41 PM
$CVRX my condolences to Donald.
0 · Reply
bballz
bballz Aug. 5 at 2:01 PM
$CVRX the company should stop posting first implant pictures... embarrassing, right Donald?
1 · Reply
bballz
bballz Aug. 5 at 1:35 PM
$CVRX sales channel challenges continue to burden investors.
0 · Reply
bballz
bballz Aug. 5 at 1:03 PM
$CVRX dead $$$ until real sales traction is noted.
0 · Reply
JarvisFlow
JarvisFlow Aug. 5 at 12:30 PM
Cantor Fitzgerald updates rating for CVRx ( $CVRX ) to Overweight, target set at 11.
0 · Reply
MITornado
MITornado Aug. 4 at 9:11 PM
$CVRX Good call. We’ll get there eventually. Slow and steady.
1 · Reply
bballz
bballz Aug. 4 at 9:00 PM
$CVRX Ceo says sales reps are gaining traction, cant wait to see what that looks like in increased revenue/guidance next year, right Donald?
1 · Reply
bballz
bballz Aug. 4 at 8:23 PM
$CVRX Lowered high end revenue guidance from $58 to 57m...upped low end expense from $95 to 96m
0 · Reply
bballz
bballz Aug. 4 at 7:15 PM
$CVRX look for the other shoe to drop
1 · Reply
bballz
bballz Jul. 31 at 1:58 PM
$CVRX anticipating flat to lower guidance.
1 · Reply
1111tu
1111tu Jul. 29 at 7:36 PM
$CVRX A decent summary. https://www.ainvest.com/news/cvrx-barostim-gains-traction-cms-reimbursement-policies-shift-gears-2507/
1 · Reply
commoncentsinvestor
commoncentsinvestor Jul. 29 at 12:41 PM
$CVRX We’re proud to partner with Dr. Russell Ronson, Dr. Sumit Verma and team at Baptist Hospital in Pensacola, FL on their first #Barostim implant. The Baptist Heart Failure "Optimization" team is the first site on the Gulf Coast to offer Barostim and is actively involved in offering innovative therapies to improve the lives of patients with #heartfailure. Thanks to Dr. Brent Videa, Dr. Brian Payne, Libby Berg, NP, Lesa Allen-Stanton, Angela Andersen, NP, Tina Lacsamana, NP, and Toinetta Coolie, NP, the team at Baptist Heart and Vascular. https://x.com/CVRx_Barostim/status/1949914946290192628
1 · Reply
1111tu
1111tu Jul. 28 at 4:17 PM
$CVRX will it close the $9.10 gap before earnings?
1 · Reply
commoncentsinvestor
commoncentsinvestor Jul. 24 at 2:35 PM
$CVRX CVRx | Barostim Congratulations to Dr. Jeko Madjarov (Coastal Thoracic Surgical Associates), Dr. John Rommel and the team at @NovantHealth New Hanover Regional Medical Center on their 15th #Barostim implant! Thank you for advancing #heartfailure care by providing innovative therapy options to your patients. https://x.com/CVRx_Barostim/status/1948119548944675078
1 · Reply
commoncentsinvestor
commoncentsinvestor Jul. 23 at 4:44 PM
$CVRX CVRx to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call on August 4, 2025
1 · Reply
commoncentsinvestor
commoncentsinvestor Jul. 22 at 2:17 PM
$CVRX “$CVRX: The Most Underappreciated MedTech Play in Hypertension and Heart Failure” https://x.com/KapilSharmaMD/status/1947537798430642207
1 · Reply
commoncentsinvestor
commoncentsinvestor Jul. 22 at 2:10 PM
$CVRX We're honored to support Drs. Marshall Bell and Luke Cunningham and the team at INTEGRIS Health Baptist Medical Center on their first #Barostim implant. Their patients now have access to a novel device therapy to improve symptoms of #heartfailure. https://x.com/CVRx_Barostim/status/1947419039921541153
0 · Reply
bballz
bballz Jul. 22 at 12:51 PM
$CVRX Tick tock: https://www.tipranks.com/news/company-announcements/cvrx-enhances-board-with-strategic-new-appointments?utm_source=alphanewsstream.com&utm_medium=referral
1 · Reply
1111tu
1111tu Jul. 21 at 9:15 PM
$CVRX 2Q Earnings CC at 4:30 EDT on August 4.
0 · Reply
MedDevice
MedDevice Jul. 21 at 12:16 PM
$CVRX nice run on expected news (perhaps disappointing the company and its new leadership can’t convince CMS to create a permanent APC). Earnings date not announced yet, high end of already lowered revenue guide is the floor. Update on the new study should be expected as this is pathway to collecting the data needed to drive real growth. Per center implant growth needs to be material. Costs inline with the lowered growth projection. In short, can leadership deliver?
1 · Reply
ThickStripe
ThickStripe Jul. 18 at 2:08 PM
$CVRX Any positive news on previously reported IDE study for new indicated group of patients with a category B designation would be a major contributor in 2026.
0 · Reply